Evaluation of itch intensity scales in atopic dermatitis: Differential measurement properties and associations with relevant cytokines
Journal of Investigative Dermatology · 2026
DOI: 10.1016/j.jid.2026.04.005 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Investigative Dermatology, 2026. Verfasst von Felix Witte und 8 weiteren Autor:innen. Beteiligte Einrichtung: Section Pruritus Medicine and Centre for Chronic Pruritus, Department of Dermatology, University Hospital Münster, Münster, Germany. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Pruritus, Cytokines. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Sanofi, Sanofi Aventis GmbH.
Abstract (Originalsprache)
Itch is the cardinal symptom contributing to patient burden in atopic dermatitis. Multiple validated itch scales are used in clinical trials, generating heterogeneous datasets. In addition, recent studies suggest an association between cytokine levels and disease severity in atopic dermatitis. This study aimed to compare the performance of different validated itch instruments and their relationship to blood cytokine profiles. Forty-nine adults with severe atopic dermatitis and severe itch were treated with 300 mg dupilumab for 16 weeks. At the initial assessment and after treatment, itch intensity and QOL were evaluated using various assessment tools. Peripheral blood samples were collected at both time points for cytokine profiling. All itch intensity scales demonstrated comparable responsiveness, irrespective of their dimension; however, the numerical rating scale consistently yielded higher scores than the visual analog scale. Macrophage-derived chemokine, CCL26, B-cell-activating factor, and IL-2R levels were significantly reduced after treatment and correlated with all (macrophage-derived chemokine and B-cell-activating factor) or subsets (CCL26 and IL-2R) of itch intensity and QOL scores. In conclusion, all validated itch intensity scales are suitable for routine clinical use; however, adhering to one instrument is recommended. The observed correlations between cytokine levels and itch scales suggest their potential as markers of disease burden in atopic dermatitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section Pruritus Medicine and Centre for Chronic Pruritus, Department of Dermatology, University Hospital Münster, Münster, Germany.
- Department of Dermatology, University Hospital Münster, Münster, Germany.
- Section Pruritus Medicine and Centre for Chronic Pruritus, Department of Dermatology, University Hospital Münster, Münster, Germany. Electronic address: sonja.staender@uni-muenster.de.
Förderung
- Deutsche Forschungsgemeinschaft
- Sanofi
- Sanofi Aventis GmbH
Zitieren
APA
Witte, F., Wiegmann, H., Teitge, E., Westmeier, J., Raker, V. K., Royeck, S., Zeidler, C., Agelopoulos, K., & Ständer, S. (2026). Evaluation of itch intensity scales in atopic dermatitis: Differential measurement properties and associations with relevant cytokines. Journal of Investigative Dermatology. https://doi.org/10.1016/j.jid.2026.04.005
Vancouver
Witte F, Wiegmann H, Teitge E, Westmeier J, Raker VK, Royeck S, et al. Evaluation of itch intensity scales in atopic dermatitis: Differential measurement properties and associations with relevant cytokines. Journal of Investigative Dermatology. 2026. doi:10.1016/j.jid.2026.04.005
BibTeX
@article{Witte2026,
author = {Witte, Felix and Wiegmann, Henning and Teitge, Esther and Westmeier, Jaana and Raker, Verena K and Royeck, Svenja and Zeidler, Claudia and Agelopoulos, Konstantin and Ständer, Sonja},
title = {Evaluation of itch intensity scales in atopic dermatitis: Differential measurement properties and associations with relevant cytokines},
journal = {Journal of Investigative Dermatology},
year = {2026},
doi = {10.1016/j.jid.2026.04.005}
}
EUVIMED